[1]
X. Feng, J. Li, X. Li, Y. Zhang, and W. Li, “Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights”, Acta Derm Venereol, vol. 106, pp. adv–2025, Mar. 2026.